AssetMark Inc
IDXX icon

AssetMark Inc’s Idexx Laboratories IDXX Stock Holding History

AssetMark Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4M Sell
46,428
-4,396
-9% -$2.47M 0.04% 321
2026
Q1 		$28.6M Sell
50,824
-1,945
-4% -$1.25M 0.06% 255
2025
Q4 		$35.7M Buy
52,769
+1,518
+3% +$1.03M 0.07% 215
2025
Q3 		$32.7M Sell
51,251
-13,534
-21% -$8.21M 0.07% 218
2025
Q2 		$34.7M Buy
64,785
+11,830
+22% +$5.66M 0.08% 190
2025
Q1 		$22.2M Buy
52,955
+19,151
+57% +$8.32M 0.06% 236
2024
Q4 		$14M Buy
33,804
+15,377
+83% +$6.74M 0.04% 304
2024
Q3 		$9.31M Buy
18,427
+723
+4% +$351K 0.03% 337
2024
Q2 		$8.63M Buy
17,704
+1,198
+7% +$601K 0.03% 328
2024
Q1 		$8.91M Sell
16,506
-1,364
-8% -$745K 0.03% 313
2023
Q4 		$9.92M Buy
17,870
+1,302
+8% +$611K 0.04% 270
2023
Q3 		$7.24M Buy
16,568
+1,963
+13% +$979K 0.03% 297
2023
Q2 		$7.34M Buy
14,605
+1,049
+8% +$503K 0.03% 287
2023
Q1 		$6.78M Sell
13,556
-238
-2% -$114K 0.03% 289
2022
Q4 		$5.63M Buy
13,794
+593
+4% +$230K 0.02% 284
2022
Q3 		$4.3M Buy
13,201
+1,069
+9% +$393K 0.02% 286
2022
Q2 		$4.25M Buy
12,132
+2,009
+20% +$819K 0.02% 267
2022
Q1 		$5.54M Sell
10,123
-11,593
-53% -$6.1M 0.02% 256
2021
Q4 		$14.3M Buy
21,716
+4,938
+29% +$3.1M 0.06% 200
2021
Q3 		$10.4M Buy
16,778
+667
+4% +$448K 0.05% 221
2021
Q2 		$10.2M Sell
16,111
-12,157
-43% -$6.71M 0.05% 221
2021
Q1 		$13.8M Buy
28,268
+544
+2% +$273K 0.07% 193
2020
Q4 		$13.9M Buy
27,724
+10,943
+65% +$4.9M 0.08% 188
2020
Q3 		$6.6M Sell
16,781
-8,884
-35% -$3.28M 0.04% 224
2020
Q2 		$8.31M Sell
25,665
-13,149
-34% -$3.81M 0.06% 204
2020
Q1 		$9.4M Sell
38,814
-25,628
-40% -$6.69M 0.08% 172
2019
Q4 		$16.8M Buy
64,442
+7,938
+14% +$2.09M 0.13% 157
2019
Q3 		$15.4M Sell
56,504
-4,329
-7% -$1.2M 0.13% 147
2019
Q2 		$16.7M Buy
60,833
+1,282
+2% +$316K 0.14% 134
2019
Q1 		$13.3M Buy
59,551
+456
+0.8% +$94.1K 0.12% 155
2018
Q4 		$11M Buy
59,095
+10,983
+23% +$2.25M 0.11% 153
2018
Q3 		$12M Sell
48,112
-2,042
-4% -$496K 0.11% 152
2018
Q2 		$10.9M Sell
50,154
-2,291
-4% -$472K 0.11% 156
2018
Q1 		$10M Sell
52,445
-1,749
-3% -$323K 0.1% 157
2017
Q4 		$8.47M Sell
54,194
-10,111
-16% -$1.59M 0.09% 173
2017
Q3 		$10M Buy
64,305
+63,900
+15,778% +$10.1M 0.11% 156
2017
Q2 		$65K Buy
405
+186
+85% +$30.2K ﹤0.01% 625
2017
Q1 		$34K Buy
219
+190
+655% +$26.2K ﹤0.01% 741
2016
Q4 		$3K Sell
29
-18
-38% -$2.05K ﹤0.01% 1091
2016
Q3 		$5K Sell
47
-65
-58% -$6.85K ﹤0.01% 1044
2016
Q2 		$10K Sell
112
-37
-25% -$3.18K ﹤0.01% 959
2016
Q1 		$12K Sell
149
-40
-21% -$2.88K ﹤0.01% 835
2015
Q4 		$14K Buy
+189
New +$13.5K ﹤0.01% 837

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

AssetMark Inc's IDXX Position: Q2 2026 in Review

AssetMark Inc reduced its Idexx Laboratories (IDXX) stake by 8.6% in Q2 2026, selling an estimated $2.47M and leaving 46,428 shares worth $24.4M. The position accounts for 0.04% of the portfolio, ranked #321.

AssetMark Inc first reported a position in IDXX in Q4 2015 and has held it in 43 quarters since. The position peaked at $35.7M in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • AssetMark Inc held 46,428 shares of Idexx Laboratories worth $24.4M as of Q2 2026.
  • AssetMark Inc sold 4,396 Idexx Laboratories shares in Q2 2026, an estimated $2.47M.
  • Idexx Laboratories made up 0.04% of AssetMark Inc's portfolio in Q2 2026, its #321 holding.
  • AssetMark Inc first reported a position in Idexx Laboratories in Q4 2015 and has held it in 43 quarters since.
  • AssetMark Inc's Idexx Laboratories position peaked at $35.7M in Q4 2025.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.